发明申请
- 专利标题: Memantine intravitreal implants
- 专利标题(中): 美金刚玻璃体内植入物
-
申请号: US11117879申请日: 2005-04-29
-
公开(公告)号: US20050244473A1公开(公告)日: 2005-11-03
- 发明人: Patrick Hughes , Lon Spada , Hiroshi Sugimoto , Wendy Blanda , James Chang
- 申请人: Patrick Hughes , Lon Spada , Hiroshi Sugimoto , Wendy Blanda , James Chang
- 申请人地址: US CA Irvine
- 专利权人: ALLERGAN, INC.
- 当前专利权人: ALLERGAN, INC.
- 当前专利权人地址: US CA Irvine
- 主分类号: A61K9/00
- IPC分类号: A61K9/00 ; A61K31/13 ; A61F2/00
摘要:
Biocompatible intraocular implants include an anti-excitotoxic agent and a biodegradable polymer that is effective to facilitate release of the anti-excitotoxic agent into an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants may be placed in an eye to treat or reduce the occurrence of one or more ocular conditions, such as retinal damage, including glaucoma and proliferative vitreoretinopathy.